FT Options’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

FT Options’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$164K	Buy	+66,000	New	+$7.11M	0.25%	75
2017 Q1	–	Sell	-112,300	Closed	-$69K	–	371
2016 Q4	$69K	Buy	112,300 +33,800	+43%	+$4.03M	0.08%	123
2016 Q3	$2.01M	Buy	78,500 +58,300	+289%	+$9.19M	1.6%	12
2016 Q2	$25K	Sell	20,200 -15,300	-43%	-$2.23M	0.02%	240
2016 Q1	$350K	Buy	35,500 +2,300	+7%	+$272K	0.37%	54
2015 Q4	$89K	Buy	+33,200	New	+$5.62M	0.07%	135

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

FT Options's ICPT Position: Q3 2017 in Review

FT Options opened a new position in Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2017: 20,264 shares worth $1.18M. The stake represents 1.77% of the portfolio and ranks #18 among its holdings. This is a return to the name: FT Options previously reported a position in ICPT as recently as Q4 2016.

FT Options first reported a position in ICPT in Q1 2016 and has held it in 4 quarters since. The position peaked at $1.97M in Q1 2016. 155 funds tracked by Wall St. Rank hold ICPT as of Q3 2017.

FT Options held 20,264 shares of Intercept Pharmaceuticals, Inc. worth $1.18M as of Q3 2017.
Intercept Pharmaceuticals, Inc. was a new FT Options position in Q3 2017.
Intercept Pharmaceuticals, Inc. made up 1.77% of FT Options's portfolio in Q3 2017, its #18 holding.
FT Options first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2016 and has held it in 4 quarters since.
FT Options's Intercept Pharmaceuticals, Inc. position peaked at $1.97M in Q1 2016.
155 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.